A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
BioNTech SE
BioNTech SE
Eli Lilly and Company
Kivu Bioscience Inc.
MOMA Therapeutics
Kestrel Therapeutics, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OncoC4, Inc.
Compass Therapeutics
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
Fate Therapeutics
IDEAYA Biosciences
Agenus Inc.
Radiopharm Theranostics, Ltd
GlaxoSmithKline
SystImmune Inc.
Institut Paoli-Calmettes
Eli Lilly and Company
AstraZeneca
BeOne Medicines
Sutro Biopharma, Inc.
Accent Therapeutics
Seagen Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
SEED Therapeutics, Inc.
Dana-Farber Cancer Institute
Normunity AccelCo, Inc.
NiKang Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
SystImmune Inc.
Pheon Therapeutics
Doma Biopharmaceutical(Suzhou)Co., Ltd.
M.D. Anderson Cancer Center
Eli Lilly and Company
Seagen Inc.
Dren Bio
Sairopa B.V.
NextCure, Inc.
NeoTX Therapeutics Ltd.
Blueprint Medicines Corporation
West China Hospital
SystImmune Inc.
Incyte Corporation
NiKang Therapeutics, Inc.
EtiraRx Australia Pty Ltd
Tempest Therapeutics
Pfizer